To determine the accuracy of SCreening for Occult REnal Disease (SCORED) questionnaire for CKD risk among Asian Patients - SCREEN

Study identifier:D1843R00353

ClinicalTrials.gov identifier:NCT05866276

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Real-World Multicentre Prospective Study to Determine the Accuracy of the SCORED (SCreening for Occult REnal Disease) Questionnaire for SCreening REnal Risk Early Against Nephropathy in Adult Population in Asia

Medical condition

Chronic Kidney Disease

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

1426

Study type

Observational

Age

n/a - n/a

Date

Study Start Date: 22 Jun 2023
Primary Completion Date: 31 May 2024
Study Completion Date: 31 May 2024

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jul 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria